Association of specific single nucleotide variants (SNVs) in the promoter and 3′-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and higher tumour grade of head and neck cancers
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 122, 105519
Abstract
No abstract availableKeywords
All Related Versions
This publication has 36 references indexed in Scilit:
- VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional levelNucleic Acids Research, 2013
- Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic Han group of North ChinaExperimental and Therapeutic Medicine, 2012
- Association of a Single-Nucleotide Polymorphism in the Promoter Region of the VEGF Gene with the Risk of Renal Cell CarcinomaGenetic Testing and Molecular Biomarkers, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Prospective analysis of the impact of VEGF‐A gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patientsBritish Journal of Clinical Pharmacology, 2010
- Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2010
- Influence of the VEGF-A 936C>T Germinal Polymorphism on Tumoral VEGF Expression in Head and Neck CancerPharmacogenomics, 2009
- Upregulation of Activator Protein-4 in Human Colorectal Cancer With MetastasisInternational Journal of Surgical Pathology, 2008
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100Journal of Clinical Oncology, 2008
- Functional vascular endothelial growth factor −2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progressionClinica Chimica Acta, 2008